Please see below for a list of search results.
The Human Tissue Authority (HTA) welcomes the publication of the report from the Regenerative Medicine Expert Group, “Building on our own potential: a UK pathway for regenerative medicine”.
The Human Tissue Authority (HTA) has been made aware that two HTA-licensed establishments are to enter administration. These two services are Precious Cells International Ltd and
The Human Tissue Authority (HTA) is aware that Precious Cells International (PCI) entered liquidation on Friday 23 November. The Official Receiver has been appointed as the liquidator.